Alnylam Pharmaceuticals | ALNY - Заемный капитал





Заемный капитал Изменить Дата
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
BioCryst Pharmaceuticals USD 395.4M 203K 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Incyte USD 28.42M 994K 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Moderna USD 597M 6M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.45B 7.86B 2026-03
PTC Therapeutics USD 535.52M 248.58M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 12.3B 3.42B 2026-03
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Takeda JPY 4.42T 50.32B 2026-06
Tectonic Therapeutic USD 17K 26K 2026-03
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Xencor USD 77.54M 4.59M 2026-06